Skip to main content
SleepCited

褪黑素(Melatonin) 用于 昼夜节律障碍

A

基于104项研究(7项荟萃分析、6项RCT),共2,780名参与者。58/104项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … 效果: None p<0.05

研究人群: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … 效果: None None

研究人群: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement 效果: None None

研究人群: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes 效果: None None

研究人群: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management 效果: None None

研究人群: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

研究数量

4513

受试者

Mixed

A

等级

Referenced Papers

Handbook of clinical … 2025 10 次引用
JAAPA : official … 2025 1 次引用
Clinical psychopharmacology and … 2024 14 次引用
Current opinion in … 2024 12 次引用
Current neuropharmacology 2023 38 次引用
Journal of clinical … 2023 6 次引用
Sleep and biological … 2023 6 次引用
Neurologia 2022 78 次引用
Archives of physiology … 2022 69 次引用
Neurologia 2022 47 次引用
Current neuropharmacology 2022 40 次引用
Chronobiology international 2021 47 次引用
Archives of medical … 2021 6 次引用
Neurotherapeutics : the … 2020 80 次引用
Journal of glaucoma 2020 32 次引用
Current treatment options … 2020 29 次引用
Human brain mapping 2020 15 次引用
Current sleep medicine … 2019 28 次引用
Journal of the … 2019 5 次引用
Neurologic clinics 2019
Current neurology and … 2018 39 次引用
Journal of sleep … 2017 1691 次引用
Current biology : … 2017 455 次引用
Neurological research 2017 331 次引用
Continuum (Minneapolis, Minn.) 2017 132 次引用
Current treatment options … 2017 56 次引用
FP essentials 2017 15 次引用
Annual review of … 2016 557 次引用
Neuropsychiatric disease and … 2016 6 次引用
Sleep medicine clinics 2015 75 次引用
Sleep medicine clinics 2015 67 次引用
Sleep medicine clinics 2015 30 次引用
Medwave 2015 6 次引用
Journal of clinical … 2014 19 次引用
Continuum (Minneapolis, Minn.) 2013 172 次引用
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 次引用
Postgraduate medicine 2011
Expert review of … 2010 58 次引用
Letters in applied … 2010 57 次引用
The International journal … 2010 55 次引用
Amino acids 2009 321 次引用
Travel medicine and … 2009 101 次引用
Seminars in neurology 2009 17 次引用
Tidsskrift for den … 2009 6 次引用
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 次引用
Sleep medicine 2007 201 次引用
Behavioral sleep medicine 2007
The FEBS journal 2006 56 次引用
Molecular and cellular … 2006 54 次引用
Journal of biological … 2005 316 次引用
Seminars in neurology 2004 16 次引用
Journal of neuroendocrinology 2003 719 次引用
Best practice & … 2003 339 次引用
The Cochrane database … 2002 154 次引用
Revista de neurologia 2002 35 次引用
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 次引用
The American journal … 2000 472 次引用
Medical science monitor … 2000 11 次引用
Proceedings of the … 1999 96 次引用
Reproduction, nutrition, development 1999 64 次引用
Current treatment options … 1999 23 次引用
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 次引用
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 次引用
La Revue du … 1996
Journal of psychiatry … 1994 118 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

上限: No established UL; 5 mg typically considered maximum

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

最佳服用时间: 30-60 minutes before bed

Safety & Side Effects

已报告的副作用

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

已知相互作用

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

可耐受最高摄入量: No established UL; 5 mg typically considered maximum

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 褪黑素(Melatonin) help with 昼夜节律障碍?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that 褪黑素(Melatonin) may support 昼夜节律障碍 management. Our evidence grade is A (Strong Evidence).
How much 褪黑素(Melatonin) should I take for 昼夜节律障碍?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 褪黑素(Melatonin)?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 褪黑素(Melatonin) and 昼夜节律障碍?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。